Table 1.
Characteristics of patients on dialysis in Argentina
| Characteristic | Value |
| Country population | 44,494,502 |
| Patients on hemodialysis | 29,929 |
| Patients on peritoneal dialysis | 1945 |
| Patients with functioning kidney transplant | 11,486 |
| Prevalence of hepatitis B, % | 0.2 |
| Prevalence of hepatitis C, % | 1 |
| Prevalence of HIV, % | 0.8 |
| Prevalence of diabetes, % | 28 |
| Membrane dialyzer (reuse), synthetic/substituted cellulose/cellulose, % | 83/14/4 |
| Type of vascular access, native AVF/prosthetic AVF/catheter | 70/15/15 |
| Prevalence of patients with ESA, % | 87 |
| No. of hemodialysis centers | 597 |
| Hospital-based dialysis units, % | 25 |
| Nonprofit dialysis units, % | 11 |
| No. of peritoneal dialysis centers | 79 |
| Dialysis covered by insurance, % | 100 |
| Out-of-pocket expenses, % | 0 |
| Dialysis unit staffing, nurses/technicians, % | 95/5 |
| Payment per hemodialysis session, USD | 55 |
| Patient-nurse ratio in hemodialysis units, adult/pediatric | 4–5/2–3 |
| Average length of dialysis session, h | 4 |
| Minimum patient evaluation by physician per mo | 4 |
| No. of transplant centers | 55 |
| Adjusted annual mortality dialysis rate, % | 16.48 |
| Etiology of ESKD, % | |
| Diabetes | 36.5 |
| Nephroangiosclerosis | 20 |
| Unknown cause | 17 |
| GN | 9 |
| Myeloma and amyloidosis | 1 |
| Obstructive uropathy | 6 |
| Polycystic kidney disease, adult type | 5 |
| Epidemic uremic hemolytic syndrome | 0.5 |
| Other | 5 |
| Cause of death, % | |
| Cardiovascular | 50 |
| Infection | 25 |
| Neoplasia | 6 |
| Other | 19 |